Search

James C. Yeung

Examiner (ID: 15138)

Most Active Art Unit
3406
Art Unit(s)
3401, 3749, 3105, 3743, 3404, 3405, 3406, 2899
Total Applications
2326
Issued Applications
2124
Pending Applications
58
Abandoned Applications
144

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17293469 [patent_doc_number] => 20210389308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => DETECTING ADAPTIVE IMMUNITY TO CORONAVIRUS [patent_app_type] => utility [patent_app_number] => 17/408096 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90354 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408096 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/408096
DETECTING ADAPTIVE IMMUNITY TO CORONAVIRUS Aug 19, 2021 Abandoned
Array ( [id] => 18613611 [patent_doc_number] => 20230280347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => NOVEL CANCER BIOMARKER IN PANCREATIC CANCER OR MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM [patent_app_type] => utility [patent_app_number] => 18/018121 [patent_app_country] => US [patent_app_date] => 2021-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5997 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018121 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/018121
NOVEL CANCER BIOMARKER IN PANCREATIC CANCER OR MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM Jul 25, 2021 Pending
Array ( [id] => 18629532 [patent_doc_number] => 20230288414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19 [patent_app_type] => utility [patent_app_number] => 18/017249 [patent_app_country] => US [patent_app_date] => 2021-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017249 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017249
Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19 Jul 21, 2021 Pending
Array ( [id] => 18896498 [patent_doc_number] => 20240011983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => METHOD FOR DETERMINING WHETHER A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT IS UNDERGOING A PRE-FLARE EVENT [patent_app_type] => utility [patent_app_number] => 18/016384 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016384 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/016384
METHOD FOR DETERMINING WHETHER A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT IS UNDERGOING A PRE-FLARE EVENT Jul 20, 2021 Pending
Array ( [id] => 17572171 [patent_doc_number] => 11320436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-03 [patent_title] => Methods, arrays and uses thereof [patent_app_type] => utility [patent_app_number] => 17/377473 [patent_app_country] => US [patent_app_date] => 2021-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 30897 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377473 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/377473
Methods, arrays and uses thereof Jul 15, 2021 Issued
Array ( [id] => 18316038 [patent_doc_number] => 11630113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-18 [patent_title] => Method for assigning antibody standard and determining minimum detection limit of antibody detection reagent [patent_app_type] => utility [patent_app_number] => 17/762088 [patent_app_country] => US [patent_app_date] => 2021-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4828 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762088 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/762088
Method for assigning antibody standard and determining minimum detection limit of antibody detection reagent Jul 15, 2021 Issued
Array ( [id] => 19327009 [patent_doc_number] => 12044686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-23 [patent_title] => Compositions and methods for assaying neutralizing antibodies [patent_app_type] => utility [patent_app_number] => 17/376058 [patent_app_country] => US [patent_app_date] => 2021-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13461 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376058 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/376058
Compositions and methods for assaying neutralizing antibodies Jul 13, 2021 Issued
Array ( [id] => 19702637 [patent_doc_number] => 12196656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Device and methods [patent_app_type] => utility [patent_app_number] => 17/371025 [patent_app_country] => US [patent_app_date] => 2021-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 22477 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371025 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/371025
Device and methods Jul 7, 2021 Issued
Array ( [id] => 17260053 [patent_doc_number] => 20210373038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOAI [patent_app_type] => utility [patent_app_number] => 17/367049 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367049 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/367049
Compositions and methods for purification and detection of HDL and APOAI Jul 1, 2021 Issued
Array ( [id] => 19962762 [patent_doc_number] => 12332256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-17 [patent_title] => Erythrocyte simulating particle, preparation method therefor, and quality control or calibrator containing same [patent_app_type] => utility [patent_app_number] => 17/353532 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 4101 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353532 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/353532
Erythrocyte simulating particle, preparation method therefor, and quality control or calibrator containing same Jun 20, 2021 Issued
Array ( [id] => 18560861 [patent_doc_number] => 11726101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Adrenomedullin assays and methods for determining mature adrenomedullin [patent_app_type] => utility [patent_app_number] => 17/349134 [patent_app_country] => US [patent_app_date] => 2021-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 9088 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349134 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/349134
Adrenomedullin assays and methods for determining mature adrenomedullin Jun 15, 2021 Issued
Array ( [id] => 18531134 [patent_doc_number] => 20230236205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => METHOD AND KIT FOR THE EARLY DETECTION OF SEPSIS [patent_app_type] => utility [patent_app_number] => 17/928741 [patent_app_country] => US [patent_app_date] => 2021-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928741 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/928741
METHOD AND KIT FOR THE EARLY DETECTION OF SEPSIS May 30, 2021 Pending
Array ( [id] => 19580780 [patent_doc_number] => 12146887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-19 [patent_title] => Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection [patent_app_type] => utility [patent_app_number] => 17/231209 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 70 [patent_no_of_words] => 18246 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231209 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231209
Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection Apr 14, 2021 Issued
Array ( [id] => 18377244 [patent_doc_number] => 20230152331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => FULL-LENGTH CILP AS A BIOMARKER FOR CARDIAC FIBROSIS [patent_app_type] => utility [patent_app_number] => 17/995266 [patent_app_country] => US [patent_app_date] => 2021-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995266 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995266
FULL-LENGTH CILP AS A BIOMARKER FOR CARDIAC FIBROSIS Mar 31, 2021 Pending
Array ( [id] => 17143042 [patent_doc_number] => 20210311055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => System and Method for Disease Surveillance and Disease Severity Monitoring for COVID-19 [patent_app_type] => utility [patent_app_number] => 17/212360 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212360 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/212360
System and Method for Disease Surveillance and Disease Severity Monitoring for COVID-19 Mar 24, 2021 Abandoned
Array ( [id] => 16993273 [patent_doc_number] => 20210231693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => OXIDATIVE STRESS BIOMARKERS TESTING IN CANINES [patent_app_type] => utility [patent_app_number] => 17/207254 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207254 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/207254
Oxidative stress biomarkers testing in canines Mar 18, 2021 Issued
Array ( [id] => 18306485 [patent_doc_number] => 20230110385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => NON-INVASIVE DETECTION OF SALIVARY AUTOANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/905419 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905419 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905419
NON-INVASIVE DETECTION OF SALIVARY AUTOANTIBODIES Mar 2, 2021 Pending
Array ( [id] => 17358059 [patent_doc_number] => 20220018855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => RGMa Fragment Based Diagnostic Assay [patent_app_type] => utility [patent_app_number] => 17/190135 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190135 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/190135
RGMa Fragment Based Diagnostic Assay Mar 1, 2021 Abandoned
Array ( [id] => 20623473 [patent_doc_number] => 12590978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => Method for measuring platelet activation based on soluble CLEC-2 and platelet count [patent_app_type] => utility [patent_app_number] => 17/904966 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1242 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904966 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904966
METHOD FOR MEASURING PLATELET ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELET COUNT Feb 25, 2021 Issued
Array ( [id] => 17991280 [patent_doc_number] => 20220357317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => METHOD AND KIT FOR DETECTING HUMAN a-DEFENSIN HD5, AND ANTIBODIES USED IN SAID METHOD AND KIT [patent_app_type] => utility [patent_app_number] => 17/632995 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632995 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/632995
METHOD AND KIT FOR DETECTING HUMAN a-DEFENSIN HD5, AND ANTIBODIES USED IN SAID METHOD AND KIT Jan 21, 2021 Pending
Menu